BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 16855216)

  • 1. Palytoxin: exploiting a novel skin tumor promoter to explore signal transduction and carcinogenesis.
    Wattenberg EV
    Am J Physiol Cell Physiol; 2007 Jan; 292(1):C24-32. PubMed ID: 16855216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of protein kinase signaling cascades by palytoxin.
    Wattenberg EV
    Toxicon; 2011 Mar; 57(3):440-8. PubMed ID: 21070801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of stress-activator protein kinase/c-Jun N-terminal kinase by the non-TPA-type tumor promoter palytoxin.
    Kuroki DW; Bignami GS; Wattenberg EV
    Cancer Res; 1996 Feb; 56(3):637-44. PubMed ID: 8564984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular signal regulated kinase 5 mediates signals triggered by the novel tumor promoter palytoxin.
    Charlson AT; Zeliadt NA; Wattenberg EV
    Toxicol Appl Pharmacol; 2009 Dec; 241(2):143-53. PubMed ID: 19716839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palytoxin is a non-12-O-tetradecanoylphorbol-13-acetate type tumor promoter in two-stage mouse skin carcinogenesis.
    Fujiki H; Suganuma M; Nakayasu M; Hakii H; Horiuchi T; Takayama S; Sugimura T
    Carcinogenesis; 1986 May; 7(5):707-10. PubMed ID: 2870823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogen-activated protein kinase phosphatase-3 is a tumor promoter target in initiated cells that express oncogenic Ras.
    Warmka JK; Mauro LJ; Wattenberg EV
    J Biol Chem; 2004 Aug; 279(32):33085-92. PubMed ID: 15159408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-type-specific activation of p38 protein kinase cascades by the novel tumor promoter palytoxin.
    Li S; Wattenberg EV
    Toxicol Appl Pharmacol; 1999 Oct; 160(2):109-19. PubMed ID: 10527909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular signal-regulated kinase transmits palytoxin-stimulated signals leading to altered gene expression in mouse keratinocytes.
    Warmka JK; Winston SE; Zeliadt NA; Wattenberg EV
    Toxicol Appl Pharmacol; 2002 Nov; 185(1):8-17. PubMed ID: 12460732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterologous regulation of the epidermal growth factor receptor by palytoxin, a non-12-O-tetradecanoylphorbol-13-acetate-type tumor promoter.
    Wattenberg EV; Fujiki H; Rosner MR
    Cancer Res; 1987 Sep; 47(17):4618-22. PubMed ID: 2887282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of arachidonic acid metabolism by different types of tumor promoters.
    Levine L; Fujiki H
    Carcinogenesis; 1985 Nov; 6(11):1631-4. PubMed ID: 2865014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential activation of mitogen-activated protein kinases by palytoxin and ouabain, two ligands for the Na+,K+-ATPase.
    Li S; Wattenberg EV
    Toxicol Appl Pharmacol; 1998 Aug; 151(2):377-84. PubMed ID: 9707514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The actions of TPA-type as well as non-TPA type tumor promoters and their mechanism(s) in tumor promotion].
    Fujiki H
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):758-65. PubMed ID: 2870684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of palytoxin or ouabain on growth and squamous differentiation of human bronchial epithelial cells in vitro.
    Bonnard C; Lechner JF; Gerwin BI; Fujiki H; Harris CC
    Carcinogenesis; 1988 Dec; 9(12):2245-9. PubMed ID: 2903801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of superoxide anion formation by the non-TPA type tumor promoters palytoxin and thapsigargin in porcine and human neutrophils.
    Kano S; Iizuka T; Ishimura Y; Fujiki H; Sugimura T
    Biochem Biophys Res Commun; 1987 Mar; 143(2):672-7. PubMed ID: 2882751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of neutrophil activation and epidermal cell toxicity by palytoxin and 12-O-tetradecanoylphorbol-13-acetate.
    Gabrielson EW; Kuppusamy P; Povey AC; Zweier JL; Harris CC
    Carcinogenesis; 1992 Sep; 13(9):1671-4. PubMed ID: 1356652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity studies of the nonphorbol tumor promoter palytoxin in Swiss 3T3 cells.
    Wattenberg EV; Uemura D; Byron KL; Villereal ML; Fujiki H; Rosner MR
    Cancer Res; 1989 Nov; 49(21):5837-42. PubMed ID: 2571412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitogen activated protein kinases selectively regulate palytoxin-stimulated gene expression in mouse keratinocytes.
    Zeliadt NA; Warmka JK; Wattenberg EV
    Toxicol Appl Pharmacol; 2003 Nov; 192(3):212-21. PubMed ID: 14575638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combination of palytoxin with 1-oleoyl-2-acetyl-glycerol (OAG) or insulin or interleukin-1 synergistically stimulates arachidonic acid metabolism, but combinations of 12-O-tetradecanoylphorbol-13-acetate (TPA)-type tumor promoters with OAG do not.
    Levine L; Xiao D; Fujiki H
    Carcinogenesis; 1986 Jan; 7(1):99-103. PubMed ID: 2867835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of apical vs. basolateral palytoxin on LLC-PK1 renal epithelia.
    Mullin JM; Snock KV; McGinn MT
    Am J Physiol; 1991 Jun; 260(6 Pt 1):C1201-11. PubMed ID: 1676241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium as a mediator of non-phorbol tumor promoter action. Down-modulation of the epidermal growth factor receptor by palytoxin.
    Wattenberg EV; Byron KL; Villereal ML; Fujiki H; Rosner MR
    J Biol Chem; 1989 Sep; 264(25):14668-73. PubMed ID: 2570066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.